Modern Pediatrics. Ukraine. (2025).2(146): 13-19. doi: 10.15574/SP.2025.2(146).1319
Seriakova I. Yu., Yevtushenko V. V., Kramarov S. O.
Bogomolets National Medical University, Kyiv, Ukraine

For citation: Seriakova IYu, Yevtushenko VV, Kramarov SO. (2025). Prognostic value of the IFABP marker in children with COVID-19. Modern Pediatrics. Ukraine. 2(146): 13-19. doi: 10.15574/SP.2025.2(146).1319.
Article received: Dec 27, 2024. Accepted for publication: Mar 18, 2025.

Аim – to study the prognostic value of the IFABP marker regarding the occurrence of symptoms of gastrointestinal tract damage and complicated course of COVID-19 in children.
Materials and methods. We conducted a retrospective, cohort, observational study involving children with laboratory-confirmed COVID-19, aged 0 to 18 years. Patients were divided into the main and control groups according to the course of the disease. The main group included 42 patients with complicated COVID-19, and the control group included 46 patients with uncomplicated disease. During the first day of hospitalization, blood serum was collected from 88 patients to determine the level of the IFABP biomarker by enzyme-linked immunosorbent assay. The median with the interquartile interval was determined. To determine the difference in the indicators of the compared groups, the parametric Student's t-test, nonparametric Mann-Whitney and Chi-square tests were used. The Spearman rank correlation test was used to assess the relationship. An operating characteristic curve was constructed and the optimal threshold value of the marker was calculated using the Youden Index calculation method.
Results. According to calculations, in patients of the control group, IFABP was observed at a level of 15.1±3.1 ng/ml, while in children of the main group the indicator was higher, amounting to 21.7±5.5 ng/ml. When conducting a study of the correlation of the IFABP biomarker with gastrointestinal symptoms and complicated course, a correlation relationship was found. According to the results of constructing the ROC curve, the optimal threshold value of the IFABP marker for predicting the risk of developing gastrointestinal symptoms in children with COVID-19 is 29.758 ng/ml. The optimal threshold value of the IFABP marker for predicting the risk of developing a complicated course of COVID-19 in children is 30.132 ng/ml.
Conclusions. The IFABP marker has prognostic value for the occurrence of gastrointestinal symptoms and complicated course of COVID-19 in children. The optimal threshold value of the IFABP marker for predicting the risk of developing gastrointestinal symptoms and complicated course of COVID-19 in children is 29.758 ng/ml and 30.132 ng/ml, respectively.
The study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Local Ethics Committee for all participants. Informed consent was obtained from patients.
The authors declare no conflict of interest.
Keywords: COVID-19, IFABP, children, biomarker, gastrointestinal tract, complicated course.
REFERENCES

1. Cárdenas-Jaén K, Sánchez-Luna SA, Vaillo-Rocamora A et al. (2023). Gastrointestinal symptoms and complications in patients hospitalized due to COVID-19, an international multicentre prospective cohort study (TIVURON project). Gastroenterología y Hepatología (English Edition). 46(6): 425-438. https://doi.org/10.1016/j.gastre.2023.05.002; PMCid:PMC10280146

2. Coufal S, Kokesova A, Tlaskalova-Hogenova H, Snajdauf J, Rygl M, Kverka M. (2016). Urinary Intestinal Fatty Acid-Binding Protein Can Distinguish Necrotizing Enterocolitis from Sepsis in Early Stage of the Disease. J. Immunol. Res. 2016:5727312. Epub 2016 Mar 24. https://doi.org/10.1155/2016/5727312; PMid:27110575 PMCid:PMC4823515

3. Huang X, Zhou Y, Sun Y, Wang Q.(2022). Intestinal fatty acid binding protein: A rising therapeutic target in lipid metabolism. Prog Lipid Res. 87: 101178. https://doi.org/10.1016/j.plipres.2022.101178; PMid:35780915

4. Kholod D. (2019). Fatty-acid-binding protein as a modern marker for diagnosis and efficacy of intensive therapy of gastrointestinal insufficiency syndrome in newborns. Actual problems of the modern medicine: bulletin of ukrainian medical stomatological academy. 19(2): 95-99. https://doi.org/10.31718/2077-1096.19.2.95

5. Martinez J, Rodriguez Hovnanian KM, Martinez EE. (2023). Biomarkers and Functional Assays of Epithelial Barrier Disruption and Gastrointestinal Dysmotility in Critical Illness-A Narrative Review. Nutrients. 15(18): 4052. https://doi.org/10.3390/nu15184052; PMid:37764835 PMCid:PMC10535972

6. Piton G, Belon F, Cypriani B, Regnard J, Puyraveau M et al. (2013). Enterocyte damage in critically ill patients is associated with shock condition and 28-day mortality. Crit. Care Med. 41: 2169-2176. https://doi.org/10.1097/CCM.0b013e31828c26b5; PMid:23782971

7. Saia RS, Giusti H, Luis-Silva F et al (2021). Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection. Int J Infect Dis. 113: 82-86. https://doi.org/10.1016/j.ijid.2021.09.051; PMid:34597762 PMCid:PMC8479553

8. Sun DL, Cen YY, Li SM, Li WM, Lu QP, Xu PY.(2016). Accuracy of the serum intestinal fatty-acid-binding protein for diagnosis of acute intestinal ischemia: A meta-analysis. Sci. Rep. 6: 34371. https://doi.org/10.1038/srep34371; PMid:27681959 PMCid:PMC5041130

9. Typpo KV, Larmonier CB, Deschenes J, Redford D, Kiela PR, Ghishan FK. (2015). Clinical characteristics associated with postoperative intestinal epithelial barrier dysfunction in children with congenital heart disease. Pediatr. Crit. Care Med. 16: 37-44. https://doi.org/10.1097/PCC.0000000000000256; PMid:25162512 PMCid:PMC4286428

10. Tyszko M, Lipińska-Gediga M, Lemańska-Perek A, Kobylińska K, Gozdzik W, Adamik B. (2022). Intestinal Fatty Acid Binding Protein (I-FABP) as a Prognostic Marker in Critically Ill COVID-19 Patients. Pathogens. 11(12): 1526. Published 2022 Dec 13. https://doi.org/10.3390/pathogens11121526; PMid:36558860 PMCid:PMC9784725

11. Yokoyama H, Sekino M, Funaoka H, Sato S, Araki HE et al. (2021). Association between enterocyte injury and fluid balance in patients with septic shock: A post hoc exploratory analysis of a prospective observational study. BMC Anesthesiol. 21(1): 293. https://doi.org/10.1186/s12871-021-01515-2; PMid:34814831; PMCid:PMC8609797